Equities

Pivot Pharmaceuticals Inc

Pivot Pharmaceuticals Inc

Actions
  • Price (EUR)0.263
  • Today's Change-0.002 / -0.75%
  • Shares traded0.00
  • 1 Year change--
  • Beta-1.2541
Data delayed at least 15 minutes, as of Nov 13 2018 15:45 GMT.
More ▼

Key statistics

As of last trade, Pivot Pharmaceuticals Inc (NPAT:FRA) traded at 0.263, 48.59% above the 52 week low of 0.177 set on May 17, 2018.
52-week range
Today
0.177May 17 20181.24Mar 14 2018
Markit short selling activity
Low
Med
High
Open0.262
High0.263
Low0.262
Bid0.258
Offer0.281
Previous close0.265
Average volume624.00
Shares outstanding88.68m
Free float62.50m
P/E (TTM)--
Market cap27.29m USD
EPS (TTM)-0.0362
USD
Data delayed at least 15 minutes, as of Nov 13 2018 15:45 GMT.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.